Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd has informed the stock exchanges that the trading window for its securities will be closed from 1st January, 2026 until 48 hours after the declaration of its Unaudited Financial Results for the quarter ended 31st December, 2025 (Q3 FY26). This closure is a routine regulatory requirement under the SEBI (Prohibition of Insider Trading) Regulations, 2015, and applies to all designated persons including promoters, directors, auditors, key managerial personnel, and their immediate relatives. The board meeting date to approve the Q3 results will be announced separately.
No direct impact on shareholders. This is a standard compliance filing that restricts insider trading ahead of the upcoming quarterly results announcement, which may be a key catalyst for short-term price movement.